{"id":"daily-intranasal-administration-of-insulin","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypoglycemia"},{"rate":"5-10%","effect":"Nasal congestion"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved by mimicking the natural insulin signaling pathway, promoting glucose uptake in cells and inhibiting glucose production in the liver. The intranasal route allows for direct delivery to the brain, potentially reducing the risk of hypoglycemia compared to traditional subcutaneous insulin administration.","oneSentence":"Insulin is administered intranasally to lower blood glucose levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:45:46.970Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes"},{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT05062785","phase":"PHASE1","title":"Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants","status":"COMPLETED","sponsor":"Robert Silbergleit","startDate":"2021-10-04","conditions":"Out-Of-Hospital Cardiac Arrest, Healthy","enrollment":24},{"nctId":"NCT05006599","phase":"PHASE2","title":"SNIFF - 3-Week Aptar CPS Device","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2025-05","conditions":"Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Disease, Early Onset","enrollment":""},{"nctId":"NCT02462161","phase":"PHASE1","title":"Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2015-03-20","conditions":"Alzheimer's Disease, Mild Cognitive Impairment","enrollment":24},{"nctId":"NCT06391853","phase":"NA","title":"Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study","status":"WITHDRAWN","sponsor":"Erasme University Hospital","startDate":"2024-10-01","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":""},{"nctId":"NCT06251635","phase":"NA","title":"Effects of Antipsychotics on Brain Insulin Action in Females","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-06-03","conditions":"Insulin Resistance, Menstrual Cycle, Type 2 Diabetes","enrollment":15},{"nctId":"NCT06443957","phase":"NA","title":"The Preventive Effect of Different Doses of Intranasal Insulin on Postoperative Delirium","status":"COMPLETED","sponsor":"The First Hospital of Jilin University","startDate":"2023-07-29","conditions":"Postoperative Delirium","enrollment":129},{"nctId":"NCT04687878","phase":"PHASE2","title":"The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients","status":"COMPLETED","sponsor":"dr.dargahi","startDate":"2020-01-01","conditions":"Parkinson Disease","enrollment":28},{"nctId":"NCT06072963","phase":"PHASE2","title":"COMMETS- Combination MCI Metabolic Syndrome","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-01-30","conditions":"Alzheimer Disease, Mild Cognitive Impairment, Metabolic Syndrome","enrollment":80},{"nctId":"NCT05104424","phase":"PHASE1","title":"The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions","status":"UNKNOWN","sponsor":"Ministry of Health, Saudi Arabia","startDate":"2021-12-26","conditions":"Smell Dysfunction, Taste Disorders, Taste Disorder, Secondary, Sweet","enrollment":22},{"nctId":"NCT03415061","phase":"NA","title":"Effect of Intranasal Insulin on POCD and POD","status":"UNKNOWN","sponsor":"Hiroaki Sato, MD., PhD.","startDate":"2021-11-01","conditions":"Delirium, Heart Diseases","enrollment":494},{"nctId":"NCT03081117","phase":"PHASE1, PHASE2","title":"Intranasal Insulin for the Treatment of HAND","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2017-08-01","conditions":"HIV Dementia, HIV-Associated Cognitive Motor Complex","enrollment":21},{"nctId":"NCT03182322","phase":"PHASE2","title":"PINIT Study: Primary Intranasal Insulin Trial","status":"COMPLETED","sponsor":"Technical University of Munich","startDate":"2018-05-25","conditions":"Diabetes Mellitus, Type 1","enrollment":38},{"nctId":"NCT02810392","phase":"PHASE2","title":"Intranasal Insulin and Post-stroke Cognition: A Pilot Study","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2016-04","conditions":"Stroke","enrollment":20},{"nctId":"NCT03324867","phase":"NA","title":"The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.","status":"UNKNOWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2022-04","conditions":"Cognitive Decline, Heart Diseases, Delirium","enrollment":316},{"nctId":"NCT00336674","phase":"PHASE2","title":"Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2006-12","conditions":"Type 1 Diabetes","enrollment":110},{"nctId":"NCT03277222","phase":"PHASE2","title":"Intranasal Treatment of HIV-associated Neurocognitive Disorders","status":"TERMINATED","sponsor":"University of Calgary","startDate":"2018-11-01","conditions":"HIV Associated Neurocognitive Disorder (HAND)","enrollment":4},{"nctId":"NCT02064166","phase":"PHASE2","title":"Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.","status":"COMPLETED","sponsor":"Peter Novak","startDate":"2014-02","conditions":"Parkinson Disease, Multiple System Atrophy","enrollment":15},{"nctId":"NCT02933645","phase":"NA","title":"Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2016-04","conditions":"Insulin Resistance","enrollment":10},{"nctId":"NCT02164032","phase":"PHASE2","title":"The Role of IntraNasal Insulin in Regulating HepaTic Lipid COntent in HUMANS","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2014-09","conditions":"Healthy Subjects","enrollment":20},{"nctId":"NCT00438568","phase":"PHASE2","title":"SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)","status":"COMPLETED","sponsor":"University of Washington","startDate":"2006-06","conditions":"Mild Cognitive Impairment, Alzheimer's Disease","enrollment":173},{"nctId":"NCT01469559","phase":"PHASE2","title":"Safety Study of Intranasal Insulin in Type 1 Diabetes and Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2011-08","conditions":"Diabetic Peripheral Neuropathy","enrollment":12},{"nctId":"NCT00223613","phase":"PHASE3","title":"Intranasal Insulin for Prevention of Type 1 Diabetes","status":"UNKNOWN","sponsor":"University of Turku","startDate":"1997-08","conditions":"Type 1 Diabetes","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"daily intranasal administration of insulin","genericName":"daily intranasal administration of insulin","companyName":"University of Turku","companyId":"university-of-turku","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin is administered intranasally to lower blood glucose levels. Used for Type 1 diabetes, Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}